News

Article

GRAM Adds Syringe Filling Capabilities

Grand River Aseptic Manufacturing announces first planned investment in capacity expansion.

Grand River Aseptic Manufacturing, Inc. (GRAM) announced on March 6, 2018 the addition of syringe filling capabilities at its FDA-inspected, cGMP-compliant manufacturing facility in Grand Rapids, MI. A Colanar FSV syringe filler, which can also handle cartridges, will use the existing single-use systems for small-molecule APIs and biologics projects. The equipment will be qualified and operational by the second quarter of 2018.

The capital investments were made following the announcement of a partnership deal with Arlington Capital Partners, a private equity firm. “With the support of Arlington, GRAM intends to invest heavily in building out our capabilities in the next couple of years with state-of-the-art equipment and a new facility. The new syringe filler is the first of many exciting announcements we will be making this year,” said Tom Ross, president and CEO of GRAM, in a press release. 

Source: Grand River Aseptic Manufacturing, Inc. 
 

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content